Public Employees Retirement System of Ohio Sells 2,508 Shares of Humana Inc. (NYSE:HUM)

Public Employees Retirement System of Ohio cut its stake in Humana Inc. (NYSE:HUM - Free Report) by 4.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 51,521 shares of the insurance provider's stock after selling 2,508 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Humana were worth $16,319,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pzena Investment Management LLC raised its stake in Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after buying an additional 1,955,375 shares in the last quarter. Marshall Wace LLP raised its position in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock worth $532,564,000 after acquiring an additional 774,085 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock worth $2,340,660,000 after acquiring an additional 738,701 shares in the last quarter. FMR LLC lifted its stake in shares of Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Finally, Baupost Group LLC MA bought a new stake in shares of Humana during the second quarter valued at approximately $156,933,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HUM has been the subject of several recent research reports. JPMorgan Chase & Co. raised their price objective on Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. Bank of America raised shares of Humana from an "underperform" rating to a "neutral" rating and lifted their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Truist Financial cut their price objective on shares of Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a report on Friday, October 11th. Wells Fargo & Company lowered their target price on shares of Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a report on Monday, November 4th. Finally, Jefferies Financial Group downgraded Humana from a "buy" rating to a "hold" rating and cut their price target for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $315.86.

Humana Stock Performance

Shares of NYSE HUM traded down $7.79 during midday trading on Wednesday, hitting $278.03. 1,812,242 shares of the stock traded hands, compared to its average volume of 1,844,360. The firm has a market capitalization of $33.48 billion, a P/E ratio of 24.64, a PEG ratio of 2.18 and a beta of 0.53. Humana Inc. has a one year low of $213.31 and a one year high of $488.89. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50-day moving average of $272.20 and a two-hundred day moving average of $325.92.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities analysts forecast that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.27%. Humana's dividend payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.